Recent advances in TIM-3 therapy for Alzheimer’s shed new light on potential treatments for this devastating condition, linking the TIM-3 molecule to the brain’s immune response.Researchers have uncovered that TIM-3 acts as a checkpoint inhibitor, preventing microglia from effectively clearing amyloid plaques associated with Alzheimer’s disease.